Slovakia spends most on health in Visegrad Four group
One of the reasons behind this phenomenon is low efficiency, the TASR newswire reported.
“If the efficiency were to rise to the OECD average the life expectancy in Slovakia might be extended by three months,” reads the OECD report on health expenditures, as quoted by TASR, “or alternatively Slovakia could achieve the same life expectancy at expenditures 8 percent lower.”
Public spending in Slovak health care stood at 5.6 percent of GDP in 2015 which surpasses the average figures in the Czech Republic, Hungary and Poland.
Despite this, the three countries in question record a mortality rate preventable with health-care spending that is 15 percent lower on average, a number that translates into 1,890 fewer deaths yearly in proportion to the Slovak population.
Czech, Hungarian and Polish males enjoy higher life expectancies by six months and females by five months, according to OECD.
As the analysis established, Slovaks consume more drugs than Czechs. If the consumption dropped to the level seen in the Czech Republic, the expenditures would decrease by €137-197 million.
The problem, however, remains with the high prescription rate and inefficient medication in terms of costs with additional tens of millions of euros likely to be saved in the purchase of special health equipment.
Furthermore, indebted hospitals would benefit from streamlined procurement processes of goods and services as well as from the introduction of a DRG system.
Slovakia also spends twice as much as the rest of neighbouring countries on laboratory examinations and radiodiagnosis, TASR wrote. ■